Article info

Download PDFPDF

Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054

Authors

  1. Correspondence to Alexander Eggermont; alexander.eggermont{at}prinsesmaximacentrum.nl

Citation

Eggermont A, Kicinski M, Suciu S
Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054

Publication history

  • Accepted December 7, 2021
  • First published January 18, 2022.
Online issue publication 
January 18, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.